FDA Import Refusal AEK-0351230-6/41/1 — Janssen Pharmaceuticals, Inc
The FDA refused shipment AEK-0351230-6/41/1 from Janssen Pharmaceuticals, Inc (United States) on Feb 25, 2022. The refused product falls under Drugs and Biologics — RIVAROXABAN. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Feb 25, 2022
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 61LCY42 RIVAROXABAN
- Charges
- 75